| 43,12 Euro | +0,475 +1,11 % | ||
| WKN: 858560 ISIN: US5324571083 Ticker-Symbol: LLY | Frankfurt | 22.05.13 | 18:39 Uhr |
Branche PharmaAktienmarkt S&P 100S&P 500 |
|
|
| Zeit | Aktuelle Nachrichten | |
|---|---|---|
| 13:19 | Corgenix Medical Collaborates With Eli Lilly To Develop Diagnostic Technology | |
| INDIANAPOLIS (dpa-AFX) - Corgenix Medical Corp. (CONX.OB) announced that it
has entered into a collaboration agreement with Eli Lilly and Co.(LLY) to
develop diagnostic technology in support... Mehr lesen zu: Corgenix Medical Collaborates With Eli Lilly To Develop Diagnostic Technology | ||
| 13:04 | Corgenix Announces Collaboration with Lilly | |
Mehr lesen zu: Corgenix Announces Collaboration with Lilly | ||
| 20.05. | Nuvilex, Inc. and Celgene, Corp. Can Both Replace Eli Lilly's Cancer Drug Gemzar | |
| NEW YORK, NY -- (Marketwired) -- 05/20/13 -- The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner's treatment. Two biotechnology companies... Mehr lesen zu: Nuvilex, Inc. and Celgene, Corp. Can Both Replace Eli Lilly's Cancer Drug Gemzar | ||
| 20.05. | From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients | |
| INDIANAPOLIS, May 20, 2013 /PRNewswire/ -- The many health care providers working at Eli Lilly and Company (NYSE:LLY) âˆ' including doctors, nurses, and pharmacists âˆ' play a vital role in bringing... Mehr lesen zu: From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients | ||
| 20.05. | Red Cross volunteers and Lilly join forces to help diabetes patients better manage their disease | |
Mehr lesen zu: Red Cross volunteers and Lilly join forces to help diabetes patients better manage their disease |
